Clearwater, FL -- (SBWIRE) -- 01/21/2015 -- Bulova Technologies Group, Inc. (OTC: BTGI)(the "Company") today announced the formation of Bulova Technologies Health Care Products LLC. Bulova Technologies Health Care Products will operate under the newly-created subsidiary, Bulova Technologies Advanced Products LLC, the incubator of new high-tech products intended to be developed and marketed by the Company.
Bulova Technologies Health Care Products is pursuing the development and marketing of high-tech medical products and is currently in negotiations with several entities for products which it believes to be promising.
Stephen L. Gurba, President and CEO of Bulova Technologies Group, Inc. stated, "With the creation of Bulova Technologies Health Care Products, we have established a vehicle which will focus on a number of exciting products in the medical field that will carry the Bulova Technologies name and contribute to our continued growth."
About Bulova Technologies Group, Inc.
Bulova Technologies Group, Inc. is registered with the United States Department of State Directorate of Defense Trade Controls (DDTC). The Company has an extensive history of large scale Defense Contracts for munitions, weapons systems, and combat systems.
Please visit our website at www.bulovatechgroup.com for more information.
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management.
Stephen L. Gurba
President, CEO and Chairman of the Board
Source: UPTICK Newswire